Free · Treating Metastatic RET‑Fusion Positive NSCLC Using Selcaxen 40mg

Published date: February 7, 2026 1:51 pm

Location: 2115, Burlington Tower, Business Bay, Dubai, UAE, Dubai, UAE

Healthcare experts primarily used Selcaxen 40mg Capsule for non-small cell lung cancer (NSCLC) with an metastatic RET fusion-positive genetic alterations in adults. It is also approved for treating advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer in patients 12 years and older. It is usually taken orally as prescribed by a doctor, and dosage may vary based on individual health needs. Visit Globans Pharma for such information.
Read More - https://www.globanspharma.com/products/selcaxen-40mg-capsule

Contact seller Share